Publications
Advancing Precision Medicine Products in the Costliest Disease Areas
Latest publications
Treatment Sequencing and Line of Therapy for Biologics and JAK inhibitors in Rheumatoid Arthritis Patients: Implications for Design and Uptake of New Drugs and Predictive Biomarker Diagnostics
Arthritis Care & Research – An Official Journal of the American College of Rheumatology
02/16/2026
Aqtual Platform Technology White Paper
03/04/2026
White Paper on Aqtual RA Product
03/04/2026
PRIMA-102 Clinical Study White Paper
03/04/2026
ABS0730 Treatment Sequencing and Line of Therapy for Biologics and JAK Inhibitors in Rheumatoid Arthritis Patients: Implications for Design and Uptake of New Drugs and Diagnostics
Annals of the Rheumatic Diseases
06/14/2025
POS0064 Development of a Blood-Based Cell-Free DNA Therapy Selection Test to Predict Biologic and Targeted Synthetic DMARDs Response in Rheumatoid Arthritis Patients (PRIMA-102)
Annals of the Rheumatic Diseases
06/14/2025
Development of a blood-based cell-free DNA therapy selection test to predict biologic and targeted synthetic DMARDs response in rheumatoid arthritis patients (PRIMA-102)
EULAR 2025
06/12/2025
3605: A Novel Active Chromatin Cell-free DNA (cfDNAac) Assay for Early Detection of Colorectal Cancer
ASCO 2025
05/31/2025
Development of a blood-based cell-free DNA classifier test to predict response to b/ts DMARDs in RA patients (PRIMA-102)
CCR East, 2025
05/02/2025
A Novel Blood-based Assay that Predicts Clinical Response to TNFi or JAKi in Patients with Rheumatoid Arthritis
ACR 2024
11/15/2024
Development of a blood-based cell-free DNA classifier test to predict biologic and targeted synthetic DMARDs response in rheumatoid arthritis patients (PRIMA-102)
ACR 2024
11/15/2024
Extracting regulatory active chromatin footprint from cell-free DNA
Communications Biology - Nature
09/04/2024
A Novel Blood-based Assay that Predicts Clinical Response to TNFi or JAKi in Patients with Rheumatoid Arthritis
CCR East, 2024
05/08/2024
PRIMA-102: Predicting Biologic and Targeted Synthetic DMARDs Response in Rheumatoid Arthritis Patients Using a Blood Based Cell-free DNA Classifier
CCR East, 2024
05/08/2024
Detection of non-small cell lung and bladder cancer signatures in peripheral blood using a novel active chromatin capture assay
AACR 2024
04/09/2024
A Novel Blood-Based Assay Differentiates Seropositive and Seronegative Rheumatoid Arthritis From Healthy Individuals and Those With Other Inflammatory Diseases or Osteoarthritis
ACR 2023
11/15/2023